Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Disease Markers|February 8, 2019
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma MultiformeZheng Zhao, Ke-Nan Zhang, Rui-Chao Chai, et al.Ebiomedicine|December 16, 2022
Immunological profiles of human oligodendrogliomas define two distinct molecular subtypesFan Wu, Yi-Yun Yin, Wen-Hua Fan, et al.Journal of Cellular and Molecular Medicine|October 2, 2020
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomasZheng Zhao, Guan-Zhang Li, Yu-Qing Liu, et al.Molecular Oncology|May 12, 2020
Classification of diffuse lower-grade glioma based on immunological profilingFan Wu, Zhi-Liang Wang, Kuan-Yu Wang, et al.The Journal of Pathology|May 18, 2020
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse gliomaFan Wu, Guan-Zhang Li, Han-Jie Liu, et al.Neuro-Oncology|January 4, 2026
Metabolic Profiling Defines Glioblastoma Subtypes with Distinct Prognoses and Therapeutic VulnerabilitiesFan Wu, Yi-Yun Yin, Di Wang, et al.JCI Insight|August 14, 2019
RNA processing genes characterize RNA splicing and further stratify lower-grade gliomaRui-Chao Chai, Yi-Ming Li, Ke-Nan Zhang, et al.Oncotargets and Therapy|December 11, 2019
Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma ImmunotherapyGuan-Zhang Li, Ke-Nan Zhang, Zheng Wang, et al.Journal for Immunotherapy of Cancer|October 20, 2021
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomasQiang-Wei Wang, Li-Hua Sun, Ying Zhang, et al.Pageof 2